Egyptian Market Growing 15% Annually

CAVE CREEK, AZ, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx Corporation (OTC:EDXC), a provider of innovative, plant-based, and sustainable health and skincare products, announced today that its HYLA team secured a distribution agreement and purchase order contract to sell in Egypt.  The contract exceeds $1,000,000 USD for the next 12 months, with an opening order at $200,000 USD.

According to market statistics sourced on Statista, 24% of the population in Egypt smoke a variety of tobacco products. Vape products are growing at an annual rate of 15% with over $370 million in e-cigarettes revenues in 2022. Hyla products are anticipated to be a well-received product in this market offering an alternative to nicotine-based products.

CEO of Endexx Todd Davis stated, “HYLA continues to rapidly expand in multiple international markets as demand for non-nicotine vape alternatives by Hyla continue to fill a major demand void and vacuum in the market.” Davis added, “Better Products, Better You”, Endexx continues to provide the best products that fit our motto for the past 10 years, and HYLA products are proving to exceed expectations.”

Visit: www.TryHyla.com

0% Nicotine. 100% Plant Powered

About Endexx Corporation

Endexx Corporation develops and distributes all natural, plant-derived topical skincare products.  Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.  The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

“Better Products, Better You”©

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements:

Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022.

For further information, please contact:
Endexx Corporation
Endexx@endexx.com
480-595-6900

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Tryp Therapeutics Announces Private Placement of Unsecured Convertible Debentures for Gross Proceeds of up to AUD$175,000

KELOWNA, BC / ACCESSWIRE / October 4, 2023 / Tryp Therapeutics Inc. (“Tryp”…

Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility

DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an…

CBOE CANADA WELCOMES GUARDIAN CAPITAL LP FOR INAUGURAL LAUNCH OF DEFINED MATURITY BOND ETFS

Toronto – January 9th, 2024 – Today, Cboe Canada Inc. welcomes Guardian Capital LP (“Guardian Capital”) for…